COVID-19 Records

NIH Monkeypox Smuggling Release — page 7

of 19 pages

← p.6 p.8 → · this page in the original PDF · package

'Vogel, Leatrice >> Also, please note that as the virus has been amplified in a laboratory setting UNC's Environmental Health and Safety office requires that the virus be shipped as a category A infectious substance. We can provide shipping materials if need be but the virus must be shipped with this documentation. I mention this as the shipment to Vanderbilt went category B. Our Fedex number is and if the following could be added as the customer number or PO that would be great! If you have any questions please let me know. Thank you so much! Amy Begin forwarded message: From: "Sims, Amy C" < @email.unc.edu<mailto: @email.unc.edu><mailto: @email.unc.edu>> Date: July 29, 2013 5:51:48 PM EDT To: " @niaid.nih.gov<mailto: @niaid.nih.gov><mailto: @niaid.nih.gov>" < @niaid.nih.gov<mailto: @niaid.nih.gov><mailto: @niaid.nih.gov>>, "Vogel, Leatrice (NIH/NIAID)" < @niaid.nih.gov<mailto: @niaid.nih.gov><mailto: @niaid.nih.gov>>, (NIH/NIAID)" < @mail.nih.gov<mailto: @mail.nih.gov><mailto: @mail.nih.gov>> Cc: "Baric, Ralph S" < @email.unc.edu<mailto: @email.unc.edu><mailto: @email.unc.edu>> Subject: Fwd: MERS CoV Hi, This is Amy Sims from the Baric lab. I've attached the CDC import permit form filled out for us to acquire the Jordan strain of MERS-CoV. Would you please review it and make sure that I haven't made any errors? Also, UNC's EHS requires that we receive the virus as a category A infectious shipment. Is there anything I can do to help with the shipment? Do you need anything else from me while we wait for the permit to be approved? Thank you, Amy -----Original Message----- From: Subbarao, Kanta (NIH/NIAID) [E] [mailto: @niaid.nih.gov]

This is our OCR of the page, with running headers and footers removed. The Committee's PDF is authoritative; quote from it. Machine-readable, including the uncleaned text: /api/page/monkeypox_release/7

Records on this page

RecordDateTypePages
Fwd: MERS CoV 2013-07-29 email 7–9
Re: MERS CoV 2013-08-23 email 6–7